SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-269572
Filing Date
2012-06-13
Accepted
2012-06-13 16:06:05
Documents
5
Period of Report
2012-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d364889d8k.htm 8-K 16244
2 OFFICE LEASE BY AND BETWEEN PUMA BIOTECHNOLOGY, INC. AND DWF III GATEWAY, L d364889dex101.htm EX-10.1 412483
3 GRAPHIC g3648891.jpg GRAPHIC 228469
4 GRAPHIC g3648892.jpg GRAPHIC 145065
5 GRAPHIC g3648893.jpg GRAPHIC 103136
  Complete submission text file 0001193125-12-269572.txt   1087139
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52811 | Film No.: 12905241
SIC: 2834 Pharmaceutical Preparations